Insufficient scRNA-seq data for expression of VANGL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 1719.64 | 2602 / 2642 | 99% | 89.49 | 699 / 705 |
thymus | 100% | 2371.79 | 652 / 653 | 94% | 26.59 | 569 / 605 |
ovary | 100% | 2174.35 | 180 / 180 | 94% | 43.43 | 403 / 430 |
uterus | 99% | 1876.11 | 168 / 170 | 87% | 44.61 | 401 / 459 |
prostate | 100% | 3018.84 | 245 / 245 | 74% | 18.03 | 371 / 502 |
pancreas | 97% | 902.15 | 317 / 328 | 71% | 16.04 | 126 / 178 |
esophagus | 98% | 1758.56 | 1412 / 1445 | 67% | 35.79 | 123 / 183 |
lung | 97% | 1482.52 | 560 / 578 | 67% | 33.86 | 778 / 1155 |
skin | 72% | 4518.52 | 1305 / 1809 | 82% | 33.87 | 387 / 472 |
intestine | 99% | 1567.89 | 953 / 966 | 47% | 11.39 | 249 / 527 |
bladder | 86% | 1507.24 | 18 / 21 | 59% | 23.74 | 299 / 504 |
breast | 71% | 1344.91 | 327 / 459 | 74% | 34.66 | 825 / 1118 |
stomach | 97% | 1009.44 | 349 / 359 | 47% | 11.59 | 134 / 286 |
kidney | 94% | 923.15 | 84 / 89 | 35% | 6.74 | 315 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.16 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 45.86 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 90% | 18.35 | 72 / 80 |
heart | 70% | 602.96 | 601 / 861 | 0% | 0 | 0 / 0 |
spleen | 63% | 395.60 | 153 / 241 | 0% | 0 | 0 / 0 |
adipose | 45% | 289.48 | 544 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 9% | 49.37 | 24 / 258 | 33% | 8.11 | 75 / 230 |
lymph node | 0% | 0 | 0 / 0 | 17% | 2.86 | 5 / 29 |
liver | 0% | 0 | 0 / 226 | 10% | 3.19 | 41 / 406 |
blood vessel | 8% | 49.45 | 106 / 1335 | 0% | 0 | 0 / 0 |
muscle | 4% | 20.42 | 36 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 10.96 | 13 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905515 | Biological process | non-motile cilium assembly |
GO_0036514 | Biological process | dopaminergic neuron axon guidance |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0036515 | Biological process | serotonergic neuron axon guidance |
GO_0045176 | Biological process | apical protein localization |
GO_0001843 | Biological process | neural tube closure |
GO_0035787 | Biological process | cell migration involved in kidney development |
GO_0001736 | Biological process | establishment of planar polarity |
GO_0001947 | Biological process | heart looping |
GO_0005911 | Cellular component | cell-cell junction |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | VANGL2 |
Protein name | Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2) Vang-like protein |
Synonyms | KIAA1215 STB1 |
Description | FUNCTION: Involved in the control of early morphogenesis and patterning of both axial midline structures and the development of neural plate. Plays a role in the regulation of planar cell polarity, particularly in the orientation of stereociliary bundles in the cochlea. Required for polarization and movement of myocardializing cells in the outflow tract and seems to act via RHOA signaling to regulate this process. Required for cell surface localization of FZD3 and FZD6 in the inner ear (By similarity). . |
Accessions | ENST00000368061.3 A0A8Q3SIN7 Q9ULK5 ENST00000696602.1 |